Literature DB >> 29296909

Primum non nocere: the case against transplant for children with sickle cell anemia without progressive end-organ disease.

Michael R DeBaun1, Ellen Wright Clayton2,2.   

Abstract

This article has a companion Point by Fitzhugh and Walters.

Entities:  

Year:  2017        PMID： 29296909      PMCID： PMC5728629          DOI： 10.1182/bloodadvances.2017007690

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  14 in total

1.  Prediction of adverse outcomes in children with sickle cell disease.

Authors:  S T Miller; L A Sleeper; C H Pegelow; L E Enos; W C Wang; S J Weiner; D L Wethers; J Smith; T R Kinney
Journal:  N Engl J Med       Date:  2000-01-13       Impact factor: 91.245

2.  Stroke With Transfusions Changing to Hydroxyurea (SWiTCH).

Authors:  Russell E Ware; Ronald W Helms
Journal:  Blood       Date:  2012-02-07       Impact factor: 22.113

3.  Survival among children and adults with sickle cell disease in Belgium: Benefit from hydroxyurea treatment.

Authors:  Phu Quoc Lê; Béatrice Gulbis; Laurence Dedeken; Sophie Dupont; Anna Vanderfaeillie; Catherine Heijmans; Sophie Huybrechts; Christine Devalck; André Efira; Marie-Françoise Dresse; Laurence Rozen; Fleur Samantha Benghiat; Alina Ferster
Journal:  Pediatr Blood Cancer       Date:  2015-07-14       Impact factor: 3.167

4.  Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study.

Authors:  Agnes Dechartres; Isabelle Boutron; Ludovic Trinquart; Pierre Charles; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2011-07-05       Impact factor: 25.391

5.  Transcranial Doppler ultrasonography and prophylactic transfusion program is effective in preventing overt stroke in children with sickle cell disease.

Authors:  Henrietta Enninful-Eghan; Reneé H Moore; Rebecca Ichord; Kim Smith-Whitley; Janet L Kwiatkowski
Journal:  J Pediatr       Date:  2010-09       Impact factor: 4.406

6.  Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.

Authors:  Michael R DeBaun; Mae Gordon; Robert C McKinstry; Michael J Noetzel; Desiree A White; Sharada A Sarnaik; Emily R Meier; Thomas H Howard; Suvankar Majumdar; Baba P D Inusa; Paul T Telfer; Melanie Kirby-Allen; Timothy L McCavit; Annie Kamdem; Gladstone Airewele; Gerald M Woods; Brian Berman; Julie A Panepinto; Beng R Fuh; Janet L Kwiatkowski; Allison A King; Jason M Fixler; Melissa M Rhodes; Alexis A Thompson; Mark E Heiny; Rupa C Redding-Lallinger; Fenella J Kirkham; Natalia Dixon; Corina E Gonzalez; Karen A Kalinyak; Charles T Quinn; John J Strouse; J Philip Miller; Harold Lehmann; Michael A Kraut; William S Ball; Deborah Hirtz; James F Casella
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

7.  Pattern of Lung Function Is Not Associated with Prior or Future Morbidity in Children with Sickle Cell Anemia.

Authors:  Robyn T Cohen; Robert C Strunk; Mark Rodeghier; Carol L Rosen; Fenella Jane Kirkham; Jane Kirkby; Michael R DeBaun
Journal:  Ann Am Thorac Soc       Date:  2016-08

8.  Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.

Authors:  Monica L Hulbert; Robert C McKinstry; JoAnne L Lacey; Christopher J Moran; Julie A Panepinto; Alexis A Thompson; Sharada A Sarnaik; Gerald M Woods; James F Casella; Baba Inusa; Jo Howard; Fenella J Kirkham; Kofi A Anie; Jonathan E Mullin; Rebecca Ichord; Michael Noetzel; Yan Yan; Mark Rodeghier; Michael R Debaun
Journal:  Blood       Date:  2010-10-12       Impact factor: 22.113

9.  Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.

Authors:  Eliane Gluckman; Barbara Cappelli; Francoise Bernaudin; Myriam Labopin; Fernanda Volt; Jeanette Carreras; Belinda Pinto Simões; Alina Ferster; Sophie Dupont; Josu de la Fuente; Jean-Hugues Dalle; Marco Zecca; Mark C Walters; Lakshmanan Krishnamurti; Monica Bhatia; Kathryn Leung; Gregory Yanik; Joanne Kurtzberg; Nathalie Dhedin; Mathieu Kuentz; Gerard Michel; Jane Apperley; Patrick Lutz; Bénédicte Neven; Yves Bertrand; Jean Pierre Vannier; Mouhab Ayas; Marina Cavazzana; Susanne Matthes-Martin; Vanderson Rocha; Hanadi Elayoubi; Chantal Kenzey; Peter Bader; Franco Locatelli; Annalisa Ruggeri; Mary Eapen
Journal:  Blood       Date:  2016-12-13       Impact factor: 22.113

10.  Clinical outcomes in children with sickle cell disease living in England: a neonatal cohort in East London.

Authors:  Paul Telfer; Pietro Coen; Subarna Chakravorty; Olu Wilkey; Jane Evans; Heather Newell; Beverley Smalling; Roger Amos; Adrian Stephens; David Rogers; Fenella Kirkham
Journal:  Haematologica       Date:  2007-07       Impact factor: 9.941
View more
  2 in total

1.  Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease.

Authors:  Ruta Brazauskas; Graziana M Scigliuolo; Hai-Lin Wang; Barbara Cappelli; Annalisa Ruggeri; Courtney D Fitzhugh; Jane S Hankins; Julie Kanter; Joerg J Meerpohl; Julie A Panepinto; Damiano Rondelli; Shalini Shenoy; Mark C Walters; John E Wagner; John F Tisdale; Eliane Gluckman; Mary Eapen
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 2.  Genetic therapies for the first molecular disease.

Authors:  Phillip A Doerfler; Akshay Sharma; Jerlym S Porter; Yan Zheng; John F Tisdale; Mitchell J Weiss
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.